| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |